Ribosomal protein S11 influences glioma response to TOP2 poisons
- 11 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 39 (27), 5068-5081
- https://doi.org/10.1038/s41388-020-1342-0
Abstract
Topoisomerase II poisons are one of the most common class of chemotherapeutics used in cancer. We and others had shown that a subset of glioblastomas, the most malignant of all primary brain tumors in adults, is responsive to TOP2 poisons. To identify genes that confer susceptibility to this drug in gliomas, we performed a genome-scale CRISPR knockout screen with etoposide. Genes involved in protein synthesis and DNA damage were implicated in etoposide susceptibility. To define potential biomarkers for TOP2 poisons, CRISPR hits were overlapped with genes whose expression correlates with susceptibility to this drug across glioma cell lines, revealing ribosomal protein subunit RPS11, 16, and 18 as putative biomarkers for response to TOP2 poisons. Loss of RPS11 led to resistance to etoposide and doxorubicin and impaired the induction of proapoptotic gene APAF1 following treatment. The expression of these ribosomal subunits was also associated with susceptibility to TOP2 poisons across cell lines from gliomas and multiple other cancers.This publication has 53 references indexed in Scilit:
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II studyBritish Journal of Cancer, 2009
- DNA topoisomerase II and its growing repertoire of biological functionsNature Reviews Cancer, 2009
- Targeting DNA topoisomerase II in cancer chemotherapyNature Reviews Cancer, 2009
- GSEA-P: a desktop application for Gene Set Enrichment AnalysisBioinformatics, 2007
- Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adultsNeuro-Oncology, 2007
- Cell Apoptosis: Requirement of H2AX in DNA Ladder Formation, but Not for the Activation of Caspase-3Molecular Cell, 2006
- The Apoptosome Activates Caspase-9 by DimerizationMolecular Cell, 2006
- The Nematode Death Machine in 3DCell, 2005
- A Role for Proapoptotic BID in the DNA-Damage ResponseCell, 2005